Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Cognito Therapeutics has reached its enrolment goal for the randomised, sham-controlled HOPE Study investigating the Spectris ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

GREEN BAY, Wis. (WBAY) - Brad Spakowitz heads into the holiday weekend with a burst of ideas and explosion of excitement.

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...